List of Tables
Table 1. Global Rivaroxaban Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Rivaroxaban Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Rivaroxaban Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Rivaroxaban Drugs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Rivaroxaban Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Rivaroxaban Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Rivaroxaban Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Rivaroxaban Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Rivaroxaban Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Rivaroxaban Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Rivaroxaban Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Rivaroxaban Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rivaroxaban Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Rivaroxaban Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rivaroxaban Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Rivaroxaban Drugs Sales by Region (K Units), 2021–2026
Table 18. Global Rivaroxaban Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Rivaroxaban Drugs Sales by Region (K Units), 2027–2032
Table 20. Global Rivaroxaban Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Rivaroxaban Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Rivaroxaban Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Rivaroxaban Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Rivaroxaban Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Rivaroxaban Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Rivaroxaban Drugs Sales by Country (K Units), 2021–2026
Table 27. North America Rivaroxaban Drugs Sales by Country (K Units), 2027–2032
Table 28. North America Rivaroxaban Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Rivaroxaban Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Rivaroxaban Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Rivaroxaban Drugs Sales by Country (K Units), 2021–2026
Table 32. Europe Rivaroxaban Drugs Sales by Country (K Units), 2027–2032
Table 33. Europe Rivaroxaban Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Rivaroxaban Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Rivaroxaban Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Rivaroxaban Drugs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Rivaroxaban Drugs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Rivaroxaban Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Rivaroxaban Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Rivaroxaban Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Rivaroxaban Drugs Sales by Country (K Units), 2021–2026
Table 42. Latin America Rivaroxaban Drugs Sales by Country (K Units), 2027–2032
Table 43. Latin America Rivaroxaban Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Rivaroxaban Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Rivaroxaban Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Rivaroxaban Drugs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Rivaroxaban Drugs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Rivaroxaban Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Rivaroxaban Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Rivaroxaban Drugs Sales (K Units) by Type (2021–2026)
Table 51. Global Rivaroxaban Drugs Sales (K Units) by Type (2027–2032)
Table 52. Global Rivaroxaban Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Rivaroxaban Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Rivaroxaban Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Rivaroxaban Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Rivaroxaban Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Rivaroxaban Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Rivaroxaban Drugs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Rivaroxaban Drugs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Rivaroxaban Drugs Sales (K Units) by Application (2021–2026)
Table 61. Global Rivaroxaban Drugs Sales (K Units) by Application (2027–2032)
Table 62. Global Rivaroxaban Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Rivaroxaban Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Rivaroxaban Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Rivaroxaban Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Rivaroxaban Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Rivaroxaban Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Rivaroxaban Drugs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Rivaroxaban Drugs Price (US$/Unit) by Application (2027–2032)
Table 70. Janssen Pharmaceuticals Company Information
Table 71. Janssen Pharmaceuticals Description and Business Overview
Table 72. Janssen Pharmaceuticals Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Janssen Pharmaceuticals Rivaroxaban Drugs Product
Table 74. Janssen Pharmaceuticals Recent Developments/Updates
Table 75. Bayer Company Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bayer Rivaroxaban Drugs Product
Table 79. Bayer Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Mylan Rivaroxaban Drugs Product
Table 84. Mylan Recent Developments/Updates
Table 85. Zydus Company Information
Table 86. Zydus Description and Business Overview
Table 87. Zydus Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Zydus Rivaroxaban Drugs Product
Table 89. Zydus Recent Developments/Updates
Table 90. Lupin Company Information
Table 91. Lupin Description and Business Overview
Table 92. Lupin Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Lupin Rivaroxaban Drugs Product
Table 94. Lupin Recent Developments/Updates
Table 95. Natco Pharma Company Information
Table 96. Natco Pharma Description and Business Overview
Table 97. Natco Pharma Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Natco Pharma Rivaroxaban Drugs Product
Table 99. Natco Pharma Recent Developments/Updates
Table 100. Shanghai Huilun Pharmaceutical Company Information
Table 101. Shanghai Huilun Pharmaceutical Description and Business Overview
Table 102. Shanghai Huilun Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Shanghai Huilun Pharmaceutical Rivaroxaban Drugs Product
Table 104. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 105. Qilu Pharmaceutical Company Information
Table 106. Qilu Pharmaceutical Description and Business Overview
Table 107. Qilu Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Qilu Pharmaceutical Rivaroxaban Drugs Product
Table 109. Qilu Pharmaceutical Recent Developments/Updates
Table 110. HEC Pharma Company Information
Table 111. HEC Pharma Description and Business Overview
Table 112. HEC Pharma Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. HEC Pharma Rivaroxaban Drugs Product
Table 114. HEC Pharma Recent Developments/Updates
Table 115. Beijing SL Pharmaceutical Company Information
Table 116. Beijing SL Pharmaceutical Description and Business Overview
Table 117. Beijing SL Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Beijing SL Pharmaceutical Rivaroxaban Drugs Product
Table 119. Beijing SL Pharmaceutical Recent Developments/Updates
Table 120. Huahai Pharmaceutical Company Information
Table 121. Huahai Pharmaceutical Description and Business Overview
Table 122. Huahai Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Huahai Pharmaceutical Rivaroxaban Drugs Product
Table 124. Huahai Pharmaceutical Recent Developments/Updates
Table 125. Yangtze River Pharmaceutical Company Information
Table 126. Yangtze River Pharmaceutical Description and Business Overview
Table 127. Yangtze River Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Yangtze River Pharmaceutical Rivaroxaban Drugs Product
Table 129. Yangtze River Pharmaceutical Recent Developments/Updates
Table 130. Fujian Cosunter Pharmaceutical Company Information
Table 131. Fujian Cosunter Pharmaceutical Description and Business Overview
Table 132. Fujian Cosunter Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Fujian Cosunter Pharmaceutical Rivaroxaban Drugs Product
Table 134. Fujian Cosunter Pharmaceutical Recent Developments/Updates
Table 135. Zhejiang Conba Pharmaceutical Company Information
Table 136. Zhejiang Conba Pharmaceutical Description and Business Overview
Table 137. Zhejiang Conba Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Zhejiang Conba Pharmaceutical Rivaroxaban Drugs Product
Table 139. Zhejiang Conba Pharmaceutical Recent Developments/Updates
Table 140. Beijing Baiao Pharmaceutical Company Information
Table 141. Beijing Baiao Pharmaceutical Description and Business Overview
Table 142. Beijing Baiao Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Beijing Baiao Pharmaceutical Rivaroxaban Drugs Product
Table 144. Beijing Baiao Pharmaceutical Recent Developments/Updates
Table 145. Lunan Pharmaceutical Company Information
Table 146. Lunan Pharmaceutical Description and Business Overview
Table 147. Lunan Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Lunan Pharmaceutical Rivaroxaban Drugs Product
Table 149. Lunan Pharmaceutical Recent Developments/Updates
Table 150. Chia Tai Tianqing Pharmaceutical Company Information
Table 151. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 152. Chia Tai Tianqing Pharmaceutical Rivaroxaban Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chia Tai Tianqing Pharmaceutical Rivaroxaban Drugs Product
Table 154. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Rivaroxaban Drugs Distributors List
Table 158. Rivaroxaban Drugs Customers List
Table 159. Rivaroxaban Drugs Market Trends
Table 160. Rivaroxaban Drugs Market Drivers
Table 161. Rivaroxaban Drugs Market Challenges
Table 162. Rivaroxaban Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. Authors List of This Report
List of Figures
Figure 1. Product Picture of Rivaroxaban Drugs
Figure 2. Global Rivaroxaban Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Rivaroxaban Drugs Market Share by Type: 2025 & 2032
Figure 4. Tablets Product Picture
Figure 5. Oral Suspension Product Picture
Figure 6. Global Rivaroxaban Drugs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Rivaroxaban Drugs Market Share by Application: 2025 & 2032
Figure 8. Deep Vein Thrombosis
Figure 9. Pulmonary Embolism
Figure 10. Atrial Fibrillation
Figure 11. Other
Figure 12. Global Rivaroxaban Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Rivaroxaban Drugs Market Size (US$ Million), 2021–2032
Figure 14. Global Rivaroxaban Drugs Sales (K Units), 2021–2032
Figure 15. Global Rivaroxaban Drugs Average Price (US$/Unit), 2021–2032
Figure 16. Rivaroxaban Drugs Report Years Considered
Figure 17. Rivaroxaban Drugs Sales Share by Manufacturers in 2025
Figure 18. Global Rivaroxaban Drugs Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Rivaroxaban Drugs Players: Market Share by Revenue in Rivaroxaban Drugs in 2025
Figure 20. Rivaroxaban Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Rivaroxaban Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Rivaroxaban Drugs Sales Market Share by Country (2021–2032)
Figure 23. North America Rivaroxaban Drugs Revenue Market Share by Country (2021–2032)
Figure 24. United States Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Rivaroxaban Drugs Sales Market Share by Country (2021–2032)
Figure 27. Europe Rivaroxaban Drugs Revenue Market Share by Country (2021–2032)
Figure 28. Germany Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Rivaroxaban Drugs Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Rivaroxaban Drugs Revenue Market Share by Region (2021–2032)
Figure 35. China Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Rivaroxaban Drugs Sales Market Share by Country (2021–2032)
Figure 43. Latin America Rivaroxaban Drugs Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Rivaroxaban Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Rivaroxaban Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Rivaroxaban Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Rivaroxaban Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Rivaroxaban Drugs by Type (2021–2032)
Figure 55. Global Rivaroxaban Drugs Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Rivaroxaban Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Rivaroxaban Drugs by Application (2021–2032)
Figure 58. Global Rivaroxaban Drugs Price (US$/Unit) by Application (2021–2032)
Figure 59. Rivaroxaban Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
